Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
It has been suggested that imbalance between TCA-cycle flux and β-oxidation may underlie insulin resistance, a predisposing factor for the development of type 2 diabetes mellitus. Acetylcarnitine concentration is suggested to be a marker of such imbalance. It is expected that when TCA-cycle capacity is high (a high oxidative capacity), less acetylcarnitine will accumulate, because of an improved balance between supply and demand of lipids.
The major research objective is to examine if acute exercise results in a more pronounced increase in acetylcarnitine concentration in sedentary subjects compared to endurance-trained subjects and if the exercise-induced increase in acetylcarnitine is restored more quickly in endurance-trained subjects when compared to sedentary subjects.
The investigators hypothesize that the increase in acetylcarnitine levels will be lower in trained subjects when compared to sedentary subjects, due to a better balance between lipid supply and utilization by the TCA-cycle. Furthermore it is expected that acetylcarnitine concentrations will be restored faster in these trained subjects, because of a tighter regulation of influx of fatty acids.
To test this hypothesis the investigators want to compare the acetylcarnitine response to exercise in a group of sedentary subjects and a group of endurance trained subjects. This response will be measured for 30 minutes after exercise with the use of 1H-MRS.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endurance Trained Subjects | Other |
| |
| Untrained Subjects | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cycling | Other | 30 minutes of cycling at 50% of predetermined maximal performance |
|
| Measure | Description | Time Frame |
|---|---|---|
| Exercise-induced changes in acetylcarnitine concentrations and dynamics of acetylcarnitine restoration after exercise | Acetylcarnitine concentration measured with Proton Magnetic Resonance Spectroscopy (1H-MRS) | During 30 minutes prior to the exercise and for 30 minutes after exercise |
| Measure | Description | Time Frame |
|---|---|---|
| Substrate oxidation | Measured with indirect calorimetry | Measured during the 30 minutes of exercise |
| Blood plasma free fatty acids | Blood sample of 10 mL |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Any medical condition requiring treatment and/or medication use OR diminishing exercise tolerance
Alcohol consumption of more than 20 g per day (± 2 units)
Unstable body weight (weight gain or loss > 3 kg in the past three months)
Participation in another biomedical study within 1 month prior to the screening visit
Contraindications for MRI scan:
Subjects, who do not want to be informed about unexpected medical findings cannot participate in the study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Vera B. Schrauwen-Hinderling, PhD. | Maastricht University Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maastricht University Medical Center | Maastricht | Limburg | 6202 AZ | Netherlands |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| At the start and at the end of 30 minutes of exercise |
| Blood plasma triglycerides | Blood sample of 10 mL | At the start and at the end of 30 minutes of exercise |
| Blood plasma glucose | Blood sample of 10 mL | At the start and at the end of 30 minutes of exercise |
| D004700 | Endocrine System Diseases |